Our in vitro results demonstrating downregulation of surface NKG2D expression on NK cells and CD8+ T cells by 22Rv1 exosomes suggested to us that NKG2D expression in lymphocytes from PC patients could be impaired. The gene discussed is KLRK1; the disease is pachyonychia congenita.